Clover Biopharmaceuticals, Ltd. 2197.HK
2197.HK
Clover Biopharmaceuticals, Ltd. 2179.HK
Jiangsu Recbio Technology Co., Ltd. 6996.HK
Antengene Corporation Limited 2487.HK
Cutia Therapeutics 2552.HK
Hua Medicine (Shanghai) Ltd. 3880.HK
Medtide Inc. 6929.HK
OrbusNeich Medical Group Holdings Limited 2508.HK
Saint Bella Inc. 1541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 6660.HK
AIM Vaccine Co., Ltd.
Clover Biopharmaceuticals, Ltd. 2179.HK
Jiangsu Recbio Technology Co., Ltd. 6996.HK
Antengene Corporation Limited 2487.HK
Cutia Therapeutics 2552.HK
Hua Medicine (Shanghai) Ltd. 3880.HK
Medtide Inc. 6929.HK
OrbusNeich Medical Group Holdings Limited 2508.HK
Saint Bella Inc. 1541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 6660.HK
AIM Vaccine Co., Ltd.
Performance
| Periode | 2197.HK | 2179.HK | 6996.HK | 2487.HK | 2552.HK | 3880.HK | 6929.HK | 2508.HK | 1541.HK | 6660.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 1 022.45 % | -4.98 % | 97.38 % | 70.43 % | 91.71 % | -0.65 % | 23.58 % | 3.97 % | 107.33 % | 21.95 % |
| YTD | 852.38 % | -28.40 % | 675.00 % | 29.08 % | 155.17 % | -0.65 % | 20.95 % | 3.97 % | 122.77 % | -33.33 % |
| 1Y | 566.67 % | -22.33 % | 527.38 % | -30.83 % | 141.83 % | -0.65 % | 28.45 % | 3.97 % | 93.89 % | -40.65 % |
| 3Y | 26.44 % | -72.51 % | 55.00 % | -62.19 % | 52.89 % | -0.65 % | -50.16 % | 3.97 % | -46.36 % | -80.58 % |
| 5Y | -83.05 % | -73.54 % | -71.17 % | -62.19 % | -19.91 % | -0.65 % | -50.16 % | 3.97 % | -46.36 % | -75.99 % |
| 10Y | -83.05 % | -73.54 % | -71.17 % | -62.19 % | -55.31 % | -0.65 % | -50.16 % | 3.97 % | -46.36 % | -75.99 % |
| From the beginning | -83.05 % | -73.54 % | -71.17 % | -62.19 % | -55.31 % | -0.65 % | -50.16 % | 3.97 % | -46.36 % | -75.99 % |